StockNews.AI
WBA
StockNews.AI
189 days

Walgreens Boots Alliance, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - WBA

1. Walgreens faces a class action lawsuit for alleged securities fraud. 2. The lawsuit involves claims of false statements and regulatory violations. 3. Allegations suggest Walgreens practices could lead to civil liability. 4. Investors may seek compensation for losses between April 2020 and January 2025. 5. The firm involved has a strong track record in securities litigation.

4m saved
Insight
Article

FAQ

Why Bearish?

The fraud allegations could negatively impact investor confidence, similar to past incidents affecting stock performance.

How important is it?

Class action lawsuits can significantly impact a company's stock price due to potential damages.

Why Short Term?

The immediate nature of lawsuit announcements can lead to swift market reactions, akin to similar lawsuits in the past.

Related Companies

NEW YORK, Feb. 11, 2025

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) of a class action securities lawsuit.

CLASS DEFINITION:

The lawsuit seeks to recover losses on behalf of Walgreens investors who were adversely affected by alleged securities fraud between April 2, 2020 and January 16, 2025. Follow the link below to get more information and be contacted by a member of our team:

Walgreens Lawsuit Submission Form

WBA investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS:

The filed complaint alleges that defendants made false statements and/or concealed that:

  1. (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same;
  2. (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm;
  3. (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and
  4. (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT'S NEXT?

If you suffered a loss in Walgreens during the relevant time frame, you have until March 31, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU:

If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY:

Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Related News